Harrow, Inc.
HROW
#5799
Rank
โ‚น110.71 B
Marketcap
โ‚น2,970
Share price
-0.71%
Change (1 day)
22.70%
Change (1 year)

Revenue for Harrow, Inc. (HROW)

Revenue in 2025 (TTM): โ‚น23.91 Billion

According to Harrow, Inc.'s latest financial reports the company's current revenue (TTM ) is โ‚น26.36 Billion. an increase over the revenue in the year 2024 that were of โ‚น17.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Harrow, Inc. from 2009 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น24.44 B42.75%
2024 โ‚น17.12 B58%
2023 โ‚น10.83 B47.84%
2022 โ‚น7.33 B35.9%
2021 โ‚น5.39 B50.93%
2020 โ‚น3.57 B-2.04%
2019 โ‚น3.64 B26.13%
2018 โ‚น2.89 B69.22%
2017 โ‚น1.70 B26.15%
2016 โ‚น1.35 B109.88%
2015 โ‚น0.64 B513.68%
2014 โ‚น0.10 B16930.45%
2013 โ‚น0.61 M-88.72%
2012 โ‚น5.47 M
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น62.15 B 135.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.87 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA